Novartis Ag (NVS)
NYSE:NVS
Holding NVS?
Track your performance easily

Novartis (NVS) Income Statement

3,560 Followers

Novartis Income Statement

Last quarter (Q4 2023), Novartis's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Novartis's net income was $―. See Novartis’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 25.93B$ 46.66B$ 43.46B$ 43.97B$ 49.90B$ 95.00B
Cost of Revenue
$ 7.56B$ 12.47B$ 11.58B$ 11.73B$ -15.12B$ -14.43B
Gross Profit
$ 18.37B$ 34.19B$ 31.88B$ 32.24B$ 34.78B$ 34.25B
Operating Expense
$ 13.97B$ 26.19B$ 23.93B$ -25.32B$ 26.37B$ 27.20B
Operating Income
$ 4.40B$ 8.00B$ 9.20B$ 11.69B$ 55.83B$ 53.37B
Net Non Operating Interest Income Expense
$ -431.00M$ -419.00M$ 574.00M$ -891.00M$ -947.00M$ -805.00M
Other Income Expense
$ -4.00M$ -1.76B$ -195.00M$ -15.34B$ -10.49B$ -2.69B
Pretax Income
$ 3.96B$ 9.12B$ 7.18B$ 26.14B$ 9.88B$ 8.94B
Tax Provision
$ 691.00M$ 551.00M$ 1.13B$ 1.63B$ 1.81B$ -5.35B
Earnings From Equity Interest Net Of Tax
-$ -13.00M$ -9.00M$ 15.34B$ 673.00M$ 659.00M
Net Income Common Stockholders
$ 3.27B$ 14.85B$ 6.96B$ 24.02B$ 8.07B$ 81.53B
Basic EPS
$ 1.50$ 7.15$ 3.19$ 10.71$ 3.55$ 5.12
Diluted EPS
$ 1.49$ 7.10$ 3.17$ 10.63$ 3.52$ 5.06
Basic Average Shares
$ 4.37B$ 2.08B$ 1.78B$ 2.24B$ 2.28B$ 2.29B
Diluted Average Shares
$ 4.39B$ 2.09B$ 1.79B$ 11.52B$ 20.35B$ 16.11B
Dividend Per Share
-$ 3.20$ 3.46---
Total Operating Income As Reported
------
Reported Normalized Basic E P S
$ 1.56-----
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 21.53B$ 38.66B$ 35.52B$ 11.31B$ 11.25B$ 12.77B
Net Income From Continuing And Discontinued Operation
$ 3.27B$ 14.85B$ 6.96B$ 24.02B$ 8.07B$ 81.53B
Normalized Income
$ 3.27B-----
Interest Expense
$ 417.00M-----
EBIT
$ 4.38B-$ 7.98B$ 25.32B$ 10.75B$ 9.79B
EBITDA
$ 8.21B-$ 14.68B$ 30.91B$ 17.21B$ 9.79B
Currency in USD

Novartis Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis